Resources

In part 2 of this Exclusive Interview, Viswanathan Mohan talks with Diabetes in Control Publisher Steve Freed about his work leading to his ADA award.

In part 3 of this Exclusive Interview, Viswanathan Mohan talks with Diabetes in Control Publisher Steve Freed about the reasoning behind higher rates of diabetes in communities of color, especially in India.

In part 4 of this Exclusive Interview, Viswanathan Mohan talks with Diabetes in Control Publisher Steve Freed about the the evolution of the Indian lifestyle leading to the increased incidence of diabetes.

In part 5 of this Exclusive Interview, Viswanathan Mohan talks with Diabetes in Control Publisher Steve Freed about his recommendations to patients regarding food choices that will still allow for rice consumption.

In part 6, the conclusion of this Exclusive Interview, Viswanathan Mohan talks with Diabetes in Control Publisher Steve Freed about the average A1C of patients in his center and his approach for achieving the best A1C per individual.

New study shows treating prediabetes risk for developing diabetes could reverse the disease before it starts.

MIDUS study looks at individual adverse childhood experiences and their impacts on future diabetes.

Will perceived quality of life be affected by increasing antidiabetes medication burden on the patient?

New study shows diuresis, canagliflozin use nearly doubled risk of complications.

In mid-November 2018, the U.S. Department of Health and Human Services finally released new physical activity guidelines (as a 2nd edition) to update their previous set from a decade before. Various activity guidelines for adults with diabetes have been updated several times in the interim, including a 2010 position statement on exercising with type 2 diabetes published jointly by the American College of Sports Medicine and the American Diabetes Association; a 2016 ADA position statement on exercise and physical activity for all types of diabetes; and a consensus statement on being active with type 1 diabetes published in The Lancet in 2017.